Beta-lactamase inhibitors and uses thereof
US10085999B1 · kind B1 · utility
4Cited by
11References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2018 |
| Grant date | Oct 2, 2018 |
| Priority date | — |
| Expiry date | Mar 23, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
β-Lactamase inhibiting compounds, therapeutic methods of using the β-lactamase inhibiting compounds, particularly in combination with β-lactam antibiotics and pharmaceutical compositions thereof are disclosed. The β-lactamase inhibiting compounds are suitable for oral administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.